Impairing temozolomide resistance driven by glioma stem-like cells with adjuvant immunotherapy targeting O-acetyl GD2 ganglioside.
Fleurence J, Bahri M, Fougeray S, Faraj S, Vermeulen S, Pinault E, Geraldo F, Oliver L, Véziers J, Marquet P, Rabé M, Gratas C, Vallette F, Pecqueur C, Paris F, Birklé S.
Fleurence J, et al. Among authors: fougeray s.
Int J Cancer. 2020 Jan 15;146(2):424-438. doi: 10.1002/ijc.32533. Epub 2019 Jul 13.
Int J Cancer. 2020.
PMID: 31241171
Free article.